3 August 2017 in The Journal of Neuroscience
Glucocorticoid has been widely accepted to induce Alzheimer9s disease (AD), but the nongenomic effect of glucocorticoid on amyloid β (Aβ) generation has yet to be studied. Here, we investigated the effect of the nongenomic pathway induced by glucocorticoid on amyloid precursor protein (APP) processing enzymes as well as Aβ production using male ICR mice and human neuroblastoma SK-N-MC cells. Mice groups exposed to restraint stress or intracerebroventricular (i.c.v.) injection of Aβ showed impaired cognition, decreased intracellular glucocorticoid receptor (GR) level, but elevated level of membrane GR (mGR). In this respect, we identified the mGR dependent pathway evoked by glucocorticoid using impermeable cortisol conjugated to BSA (cortisol-BSA) on SK-N-MC cells. Cortisol-BSA augmented the expression of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1), the level of C-Terminal Fragment β of APP (C99) and Aβ production which were maintained even after blocking intracellular GR. We also found that cortisol-BSA enhanced the interaction between mGR and Gαs which co-localized in the lipid raft. The subsequently activated CREB by cortisol-BSA bound to the CRE site of the BACE1 promoter increasing its expression, which was downregulated by inhibiting CBP. Consistently, blocking CBP attenuated cognitive impairment and Aβ production induced by corticosterone treatment or i.c.v. injection of Aβ more efficiently than inhibiting intracellular GR in mice. In conclusion, glucocorticoid couples mGR with Gαs and triggers cAMP-PKA-CREB axis dependent on the lipid raft to stimulate BACE1 upregulation and Aβ generation. SIGNIFICANCE STATEMENT Patients with Alzheimer9s disease (AD) have been growing sharply and stress is considered as the major environment factor of AD. Glucocorticoid is the primarily responsive factor to stress and is widely known to induce AD. However, most AD patients usually have impaired genomic pathway of glucocorticoid due to intracellular glucocorticoid receptor (GR) deficiency. In this respect, the genomic mechanism of glucocorticoid faces difficulties in explaining the consistent amyloid β (Aβ) production. Therefore, it is necessary to investigate the novel pathway of glucocorticoid on Aβ generation to find a more selective therapeutic approach to AD patients. In this study, we revealed the importance of nongenomic pathway induced by glucocorticoid where membrane GR plays an important role in Aβ formation.
6 June 2025 in Progress in Neurobiology
31 August 2024 in Journal of Veterinary Clinics
Siwon Jeong, Jiwoong Yoon, Woo-Jin Song, Jongtae Cheong, Young-min Yun, Gee Euhn Choi, Myung-Chul Kim. J Vet Clin 2024;41:215-22. https://doi.org/10.17555/jvc.2024.41.4.215
31 August 2024 in Journal of Veterinary Clinics
Yunhee Joung, Jiwoong Yoon, Dong Ju Lee, Woo-Jin Song, Jongtae Cheong, Hyunjung Park, Young-min Yun, Gee Euhn Choi, Myung-Chul Kim. J Vet Clin 2024;41:207-14. https://doi.org/10.17555/jvc.2024.41.4.207